2. Information that can be introduced into clinical practice
• Provision of information with clear medical significance, provision of diagnosis and
treatment if indicated*2
•

Provision of information that was of unclear medical significance at the time of
analysis but was subsequently shown to be medically significant, and provision of
diagnosis and treatment if indicated*3

3. Information relating to new personalized medical care
• Provision of opportunities for participation in clinical research or clinical trials*4
*1 Information relating to new results obtained through research or drug discovery that uses
the data accumulated by the present project will be made available as appropriate to industry
and academe to promote the use of the Analysis and Data Center. Generalized information
on these results will be made available to the public over the Internet, etc.
*2 *3 In either case, information on germline pathogenic variants, etc. that may affect the
health of the patient will be returned to the patient in line with the patient’s wishes following
discussions by an expert panel, and with proper considerations such as provision of genetic
counseling.
*4 Systems will be put in place to enable as many patients as possible to have opportunities
to take part in clinical research or clinical trials using the results of whole genome analysis.

8